hotspot -WSS

hotspot

author：comprehensive 2025-09-29 21:12:43 - browse：6

Liver illustration — Hyacinth Empinado/STAT

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage.

There are no approved medications for the disease, but among available diabetes drugs, the ADA singled out GLP-1 treatments as an option doctors could consider, according to recommendations published during the annual ADA conference.

GLP-1 treatments, such as Ozempic and Mounjaro, are a class of drugs that have grown widely popular for their efficacy not only in lowering blood sugar, but also cutting weight. Drugmakers have started to study them in liver disease, and while some trials have shown they may offer some benefits, they haven’t yet been shown to improve harmful liver scarring.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Faced with fears of OxyContin misuse, sales reps touted its safety

entertainment

WSS

GOP presidential candidates start declaring their loyalty

Medicare inequities exacerbate Puerto Rico’s health disparities

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

Medicare inequities exacerbate Puerto Rico’s health disparities

A solution to the after

leisure time

hotspot

knowledge

Heart attack and stroke risk calculators need revising

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

Trump demands the U.S. pay no more for drugs than other countries … again

The history of OxyContin, told through Purdue Pharma documents

Walensky prepares to leave CDC — and Congress — behind

White House drug shortages task force keeps mum with Congress

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

R1 RCM gets $5.8 billion buyout offer from private equity firm

Hepatitis C has a cure — but many Americans still lack access to it

Novo acquires Inversago for up to $1 billion

focus

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Target recalls 2.2 million additional candles due to laceration, burn hazards

Antivenom research: Lessons from HIV applied in search for universal antidote

White House drug shortages task force keeps mum with Congress

The history of OxyContin, told through Purdue Pharma documents

Antivenom research: Lessons from HIV applied in search for universal antidote

entertainment

focus

focus

hotspot